; (B) in paragraph (2)(C), by inserting after products the following: , and ancillary medical supplies to assist with the utilization of such products, ; and (C) in paragraph (2)(J)(v), by striking the one-year period for which the report is submitted and inserting the two-year period for which the report is submitted . (b) Countermeasures budget plan Section 2811(b)(7) of the Public Health Service Act ( 42 U.S.C. 300hh–10(b)(7) ) is amended— (1) by striking subparagraph (A) and inserting the following: (A) include consideration of the entire medical countermeasures enterprise, including— (i) basic research and advanced research and development; (ii) approval, clearance, licensure, and authorized uses of products; (iii) procurement, stockpiling, maintenance, and potential replenishment (including manufacturing capabilities) of all products in the Strategic National Stockpile; and (iv) the availability of technologies that may assist in the advanced research and development of countermeasures and opportunities to use such technologies to accelerate and navigate challenges unique to countermeasure research and development; ; (2) by redesignating subparagraphs (D) and (E) as subparagraphs (E) and (F), respectively; and (3) by inserting after subparagraph (C) the following: (D) identify the full range of anticipated medical countermeasure needs related to research and development, procurement, and stockpiling, including the potential need for indications, dosing, and administration technologies, and other countermeasure needs as applicable and appropriate; . 102. Public health emergency medical countermeasures enterprise Subtitle B of title XXVIII of the Public Health Service Act ( 42 U.S.C. 300hh–10 et seq.) is amended— (1) by redesignating section 2811A as 2811B